A new ingestible or inhalable antibody that can prevent allergic reactions and asthma in adults, could pave way for a far more effective allergy medicine.
The antibody has a unique mechanism through which it blocks the immune effect that causes the allergic reactions.
Asthma
It''s a lung condition characterized by inflammation of the bronchi and constriction of the airways that result in coughing, wheezing or breathlessness. Allergy and other airway irritants can trigger it
Advertisement
‘The antibody interacts in a complex biochemical process in the human body by which it prevents the human allergy antibody (IgE) from attaching to cells, thus keeping all allergic symptoms from occurring.’
Tweet it Now
"We can now describe the interaction of this antibody with its target and the conformational changes very accurately. This allows us to understand, how it interferes with the IgE and its specific receptors on the immune cells of the body, which are responsible for releasing histamine in an allergic reaction," said Edzard Spillner, Associate Professor at the Aarhus University.
When exposed to external allergens, an allergic person produces high levels of IgE molecules.
The function of the antibody is that it interferes with binding of IgE to the two specific effector (CD23 and FceRI) on the immune cells, thereby making it impossible for the allergy molecule to bind.
![Allergy - Symptom Evaluation]( "Allergy - Symptom Evaluation")
An allergic reaction may be mild or severe. It usually involves the skin, respiratory system, eyes, digestive system or blood pressure.
Furthermore, the scientists have observed that the antibody also removes the IgE molecules even after binding to its receptors.
"Once the IgE on immune cells can be eliminated, it doesn't matter that the body produces millions of allergen-specific IgE molecules. When we can remove the trigger, the allergic reaction and symptoms will not occur," Spillner said.
In the laboratory, it took only 15 minutes to disrupt the interaction between the allergy molecules and the immune cells.
The research team has conducted ex vivo experiments with blood cells from patients allergic to birch pollen and insect venom. However, the method can be transferred to virtually all other allergies and asthma, they said.
Because of its chemical structure, the new antibody might be inhaled or swallowed, and these new consumption methods will make easy, cheap and much and more comfortable for the patients to handle.
"It is a so-called single domain antibody which easily produced in processes using only microorganisms. It is also extremely stable, and this provides new opportunities for how the antibody can be administered to patients," Spillner said.
Source: IANS
The function of the antibody is that it interferes with binding of IgE to the two specific effector (CD23 and FceRI) on the immune cells, thereby making it impossible for the allergy molecule to bind.
Allergy - Symptom Evaluation
An allergic reaction may be mild or severe. It usually involves the skin, respiratory system, eyes, digestive system or blood pressure.
Advertisement
Furthermore, the scientists have observed that the antibody also removes the IgE molecules even after binding to its receptors.
"Once the IgE on immune cells can be eliminated, it doesn't matter that the body produces millions of allergen-specific IgE molecules. When we can remove the trigger, the allergic reaction and symptoms will not occur," Spillner said.
In the laboratory, it took only 15 minutes to disrupt the interaction between the allergy molecules and the immune cells.
The research team has conducted ex vivo experiments with blood cells from patients allergic to birch pollen and insect venom. However, the method can be transferred to virtually all other allergies and asthma, they said.
Because of its chemical structure, the new antibody might be inhaled or swallowed, and these new consumption methods will make easy, cheap and much and more comfortable for the patients to handle.
"It is a so-called single domain antibody which easily produced in processes using only microorganisms. It is also extremely stable, and this provides new opportunities for how the antibody can be administered to patients," Spillner said.
Source: IANS
Dealing with Pollen Allergy
The plants around you that give you sniffles in your nose at specific time of the year are the source of allergy causing pollens.
Advertisement
 Multiple Drug Allergy SyndromeMultiple drug allergy syndrome or multiple drug hypersensitivity syndrome is a condition that causes allergy to two or more unrelated drugs. | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
New study sheds light on the intrinsic, yet often overlooked, role of sleep preparation as a hardwired survival strategy.
Microgravity-induced bone loss in space, can be reduced by systemic delivery of NELL-1, a protein required for bone growth and its maintenance.
Researchers establish connections between Alzheimer's-linked genetic alterations and the functioning of brain cells.
Team at NeuroRestore introduces a groundbreaking gene therapy that has effectively promoted nerve regrowth and reconnection, post spinal cord injury.
Scientists aim to pinpoint particular functional pathways affected by these bacteria that may have an impact on skeletal health.
